Synergistic effects of inhibitors targeting PI3K and Aurora Kinase A in preclinical inflammatory breast cancer models
N. Al-Ali, J. Kment, S. Young, A. Craig
This study shows that combining PI3K and AURKA inhibitors synergistically kills IBC cells and reduces tumor growth and metastasis in xenograft models.
bioRxiv · Aug 11, 2023 · PreprintCancer Biology